NasdaqGS - Nasdaq Real Time Price USD

Schrödinger, Inc. (SDGR)

23.97 +0.63 (+2.70%)
At close: April 26 at 4:00 PM EDT
24.25 +0.28 (+1.17%)
After hours: April 26 at 7:29 PM EDT

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Dr. Ramy Farid Ph.D. CEO, President & Director 1.06M 1.14M 1965
Dr. Richard A. Friesner Ph.D. Co-Founder, Scientific Advisory Chairman and Director 465k -- 1953
Dr. Geoffrey Craig Porges MBBS Executive VP & CFO 888.15k -- --
Dr. Robert Lorne Abel Ph.D. Executive VP, Chief Scientific Officer of Platform and Head of Modeling R&D 569.45k -- 1982
Dr. Karen Akinsanya Ph.D. President of Research & Development Therapeutics 797.74k -- 1968
Dr. Margaret Han Dugan M.D. Chief Medical Officer 707.46k -- 1957
Prof. William Goddard III Co-Founder & Scientific Advisor -- -- --
Mr. Kenneth Patrick Lorton Executive VP, CTO & COO of Software 510.09k 395.9k 1984
Mr. Shane Brauner Executive VP & Chief Information Officer -- -- 1978
Ms. Jaren Irene Madden Senior Vice President of Investor Relations & Corporate Communications -- -- --

Schrödinger, Inc.

1540 Broadway
24th Floor
New York, NY 10036
United States
212 295 5800 https://www.schrodinger.com
Sector: 
Healthcare
Full Time Employees: 
867

Description

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.

Corporate Governance

Schrödinger, Inc.’s ISS Governance QualityScore as of April 1, 2024 is 6. The pillar scores are Audit: 5; Board: 6; Shareholder Rights: 3; Compensation: 9.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

Upcoming Events

May 01, 2024
Schrödinger, Inc. Earnings Call

Related Tickers

CERT Certara, Inc.
16.57
+1.66%
 
TDOC Teladoc Health, Inc.
13.01
-2.40%
 
TXG 10x Genomics, Inc.
27.59
+2.57%
 
DOCS Doximity, Inc.
23.82
+0.97%
 
ACCD Accolade, Inc.
7.89
-14.15%
 
PGNY Progyny, Inc.
32.04
-1.42%
 
GDRX GoodRx Holdings, Inc.
7.19
+1.55%
 
VEEV Veeva Systems Inc.
200.91
+0.91%
 
GEHC GE HealthCare Technologies Inc.
86.24
+0.34%
 
LFMD LifeMD, Inc.
11.95
+10.44%